These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 11800503

  • 1. Efficacy and safety of amisulpride 50 mg versus paroxetine 20 mg in major depression: a randomized, double-blind, parallel group study.
    Cassano GB, Jori MC, AMIMAJOR Group.
    Int Clin Psychopharmacol; 2002 Jan; 17(1):27-32. PubMed ID: 11800503
    [Abstract] [Full Text] [Related]

  • 2. Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
    Amore M, Jori MC, AMISERT Investigators.
    Int Clin Psychopharmacol; 2001 Nov; 16(6):317-24. PubMed ID: 11712619
    [Abstract] [Full Text] [Related]

  • 3. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine.
    Waintraub L, Septien L, Azoulay P.
    CNS Drugs; 2002 Dec; 16(1):65-75. PubMed ID: 11772119
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.
    Ballús C, Quiros G, De Flores T, de la Torre J, Palao D, Rojo L, Gutiérrez M, Casais L, Riesgo Y.
    Int Clin Psychopharmacol; 2000 Jan; 15(1):43-8. PubMed ID: 10836286
    [Abstract] [Full Text] [Related]

  • 6. A comparison of paroxetine versus paroxetine plus amisulpride in the treatment of dysthymic disorder: efficacy and psychosocial outcomes.
    Rocca P, Marchiaro L, Rasetti R, Rivoira E, Bogetto F.
    Psychiatry Res; 2002 Oct 10; 112(2):145-52. PubMed ID: 12429360
    [Abstract] [Full Text] [Related]

  • 7. Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission: a double-blind, comparative study.
    Smeraldi E.
    J Affect Disord; 1998 Feb 10; 48(1):47-56. PubMed ID: 9495601
    [Abstract] [Full Text] [Related]

  • 8. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine.
    Szegedi A, Kohnen R, Dienel A, Kieser M.
    BMJ; 2005 Mar 05; 330(7490):503. PubMed ID: 15708844
    [Abstract] [Full Text] [Related]

  • 9. Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators.
    Ravizza L.
    J Psychopharmacol; 1999 Mar 05; 13(3):248-54. PubMed ID: 10512080
    [Abstract] [Full Text] [Related]

  • 10. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P, Shu L, Xu X, Wang CY, Lee MS, Liu CY, Hong JP, Ruschel S, Raskin J, Colman SA, Harrison GA.
    Psychiatry Clin Neurosci; 2007 Jun 05; 61(3):295-307. PubMed ID: 17472599
    [Abstract] [Full Text] [Related]

  • 11. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.
    J Clin Psychiatry; 1996 Jun 05; 57 Suppl 2():46-52. PubMed ID: 8626363
    [Abstract] [Full Text] [Related]

  • 12. Amisulpride versus amineptine and placebo for the treatment of dysthymia.
    Boyer P, Lecrubier Y, Stalla-Bourdillon A, Fleurot O.
    Neuropsychobiology; 1999 Jun 05; 39(1):25-32. PubMed ID: 9892856
    [Abstract] [Full Text] [Related]

  • 13. A double-blind randomised comparative trial of amisulpride versus olanzapine for 2 months in the treatment of subjects with schizophrenia and comorbid depression.
    Vanelle JM, Douki S.
    Eur Psychiatry; 2006 Dec 05; 21(8):523-30. PubMed ID: 17113759
    [Abstract] [Full Text] [Related]

  • 14. Amisulpride versus risperidone in the treatment of depression in patients with schizophrenia: a randomized, open-label, controlled trial.
    Kim SW, Shin IS, Kim JM, Lee SH, Lee JH, Yoon BH, Yang SJ, Hwang MY, Yoon JS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct 01; 31(7):1504-9. PubMed ID: 17692448
    [Abstract] [Full Text] [Related]

  • 15. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH, EMBOLDEN II (Trial D1447C00134) Investigators.
    J Clin Psychiatry; 2010 Feb 01; 71(2):163-74. PubMed ID: 20122366
    [Abstract] [Full Text] [Related]

  • 16. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W, Ludwig M.
    Fortschr Neurol Psychiatr; 1994 Sep 01; 62 Suppl 1():16-8. PubMed ID: 7959520
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.
    Chaudhry HR, Qureshi Z, Tareen IA, Yazdani I.
    J Pak Med Assoc; 2002 Nov 01; 52(11):518-25. PubMed ID: 12585372
    [Abstract] [Full Text] [Related]

  • 18. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF, Kremer C, Rodrigues HE, Murphy GM, Mirtazapine vs. Paroxetine Study Group.
    Am J Geriatr Psychiatry; 2002 Nov 01; 10(5):541-50. PubMed ID: 12213688
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.
    Int Clin Psychopharmacol; 1999 Nov 01; 14(6):329-37. PubMed ID: 10565799
    [Abstract] [Full Text] [Related]

  • 20. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.
    J Clin Psychiatry; 1992 Dec 01; 53(12):434-8. PubMed ID: 1487471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.